MedPath

Effects of Elaeagnus angustifolia L. on lipid profile in menopause wome

Phase 2
Conditions
Menopause.
Menopausal and perimenopausal disorder, unspecified
Registration Number
IRCT2017073132795N3
Lead Sponsor
Damghan university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

Postmenopausal women aged 70-40 with a serum lipid level of 200-300 mg / ml and no risk factor for using the drug to lower this lipid level are invited to this study.

Major exclusion criteria: The women who suffering from cardiovascular diseases; renal and metabolic disorders such as diabetes; those using psychiatric drugs; smoking tobacco or consuming alcohol or narcotic agents are excluded from the study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath